<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01367899</url>
  </required_header>
  <id_info>
    <org_study_id>09-LJH-002</org_study_id>
    <nct_id>NCT01367899</nct_id>
  </id_info>
  <brief_title>CONSERVE Plus Post-Approval Study (PAS)</brief_title>
  <official_title>Conserve Plus Total Hip Resurfacing System: A Non-Randomized, Multi-center, NewEnrollement Post Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroPort Orthopedics Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroPort Orthopedics Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this post-approval study is to provide scientifically valid and reliable
      evidence that supports claims of longer term safety and effectiveness with regard to Month
      120 device survivorship rates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the performance of CONSERVE Plus Hip Resurfacing System under actual
      conditions of use. Additionally, this study will evaluate the performance of the device in
      the post approval environment to see if there are any significant changes in device
      performance as compared to the pre-market IDE Study
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success at Month 120</measure>
    <time_frame>10 years</time_frame>
    <description>Clinical success at Month 120 for each patient will be survivorship, defined as freedom from revision or removal for any aseptic reason and at least &quot;good&quot; function/pain relief defined as Harris Hip Score ≥ 80.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic outcomes</measure>
    <time_frame>10 years</time_frame>
    <description>Secondary measures: radiographic outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metal Ion (serum)</measure>
    <time_frame>24 months</time_frame>
    <description>metal ion (serum) and renal function will also be collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment for Adverse Events</measure>
    <time_frame>10 years</time_frame>
    <description>Subjects will be assessed for any adverse events during their length of participation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Patient Satisfaction</measure>
    <time_frame>10 years</time_frame>
    <description>Patient satisfaction as assessed by the SF-12</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">199</enrollment>
  <condition>Other and Unspecified Injury to Hip and Thigh</condition>
  <arm_group>
    <arm_group_label>CONSERVE® Plus hip resurfacing</arm_group_label>
    <description>Recipients/C Plus (IDE)study</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have already undergone hip resurfacing in the CONSERVE Plus IDE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Was previously enrolled in the CONSERVE® Plus IDE as part of the All Enrolled Audited
             Cohort (N=1366 procedures (1206 patients)) and received the &quot;Original Shell&quot;.

          2. Is willing and able to comply with the study plan and able to understand and sign the
             Patient Informed Consent Form.

        Exclusion Criteria:

          1. Patient is mentally incompetent.

          2. Patient is a prisoner.

          3. Patient is an alcohol and/or drug abuser

          4. Patient has undergone device revision or removal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bolognesi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michael Bolognesi, MD</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2011</study_first_submitted>
  <study_first_submitted_qc>June 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2011</study_first_posted>
  <last_update_submitted>October 24, 2014</last_update_submitted>
  <last_update_submitted_qc>October 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Safety</keyword>
  <keyword>Efficacy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

